Association of double-positive FOXA1 and FOXP1 immunoreactivities with favorable prognosis of tamoxifen-treated breast cancer patients.
about
Genome instability in blood cells of a BRCA1+ breast cancer family.miR-378a-3p modulates tamoxifen sensitivity in breast cancer MCF-7 cells through targeting GOLT1A.Identification of estrogen-responsive genes based on the DNA binding properties of estrogen receptors using high-throughput sequencing technologyClinicopathological significance of forkhead box protein A1 in breast cancer: A meta-analysis.Prognostic value of decreased FOXP1 protein expression in various tumors: a systematic review and meta-analysisEpstein-Barr virus encoded miR-BART11 promotes inflammation-induced carcinogenesis by targeting FOXP1.Suppression of microRNA-9 by mutant EGFR signaling upregulates FOXP1 to enhance glioblastoma tumorigenicity.FOXP1 enhances tumor cell migration by repression of NFAT1 transcriptional activity in MDA-MB-231 cells.Expression of FOXP1 and Colorectal Cancer Prognosis.Reconstruction of an integrated genome-scale co-expression network reveals key modules involved in lung adenocarcinoma.A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancer.Intratumoral estrogen production and actions in luminal A type invasive lobular and ductal carcinomas.The clinicopathological significance of forkhead box P1 and forkhead box O3a in pancreatic ductal adenocarcinomas.The relationship between the expression of FOXA1 and GATA3 and the efficacy of neoadjuvant endocrine therapy.Upregulation of FOXP1 is a new independent unfavorable prognosticator and a specific predictor of lymphatic dissemination in cutaneous melanoma patients.Impact of GATA-3 and FOXA1 expression in patients with hormone receptor-positive/HER2-negative breast cancer.Cytoplasmic FOXP1 expression is correlated with ER and calpain II expression and predicts a poor outcome in breast cancer.
P2860
Q33651926-1C4D3623-06C7-49CC-BD88-0C3D47D01F1BQ35932634-8E7C7F7E-BF67-4923-9007-8D2C6395B7EEQ36063718-92E5E45C-FA42-4570-AAC5-A0ABEF4E3A3AQ36953276-B54AD773-81BB-44BD-8167-8AB6F12C00F7Q37125561-94AC1ADC-3A43-4286-AFA9-63CA91AF640DQ37392833-BB2D2F09-006D-4E67-9964-B129C455FC2AQ37626436-3893ECA9-CDAB-41DF-8BA8-9A132E3EA50FQ38730495-92EF9442-5E7A-4336-829F-12CE3C70B6E2Q38826119-9656D210-A739-42F8-A9D1-875FBBBCBDA9Q43095950-3121239B-921E-4AE0-9B12-C85D5AC967B4Q46799300-1DF92C0E-6C75-47B9-9DC8-EFB684F5ED36Q50227670-7921B798-E60A-4206-B41B-BF5EF10BBED8Q51023001-890F8321-C6BC-4A6C-8CD9-0E676D0A52B9Q51606753-3D42DB55-3D1C-4BB1-A598-F789A21EE804Q52646028-BB7618FD-7A25-48A3-9842-9D232963143BQ54384984-261FE39B-F2A4-44E0-9E6C-A3A72F60BF6FQ55027564-A44E2DB5-42EB-4BD8-87DA-863C021A091E
P2860
Association of double-positive FOXA1 and FOXP1 immunoreactivities with favorable prognosis of tamoxifen-treated breast cancer patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Association of double-positive ...... reated breast cancer patients.
@en
Association of double-positive ...... reated breast cancer patients.
@nl
type
label
Association of double-positive ...... reated breast cancer patients.
@en
Association of double-positive ...... reated breast cancer patients.
@nl
prefLabel
Association of double-positive ...... reated breast cancer patients.
@en
Association of double-positive ...... reated breast cancer patients.
@nl
P2093
P2860
P1433
P1476
Association of double-positive ...... reated breast cancer patients.
@en
P2093
Akihiko Osaki
Chikako Shimizu
Hitoshi Tsuda
Kazuhiro Ikeda
Kenjiro Aogi
Kuniko Horie-Inoue
Nobuhiro Ijichi
Satoshi Inoue
Shigehira Saji
Takashi Shigekawa
P2860
P2888
P304
P356
10.1007/S12672-012-0111-0
P577
2012-04-03T00:00:00Z